Cell reports · 2025
Deciphering genomic evolution of metastatic organotropism with 535 paired primary lung cancers and metastases.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xie Duo, Tang Wen-Fang, Jiang Tao, Duan Hao, Mo Shanlan, Zhang Hao, Zhai Xiangwei, Tian Qingda, Li Zan, Liang Yi, Huang Wei-Zhao, Jiang Hai-Ming, On Lee Leo Tsz, Zhang Chao, Zhai Weiwei, Mou Yonggao, Zhong Wen-Zhao, Hu Zheng
Аннотация
Metastasis is the leading cause of death in lung cancer patients, yet our understanding of its genomic determinants and evolution remains limited. Here, we analyzed whole-exome sequencing data from 535 paired primary and metastatic tumors from 223 non-small cell lung cancer patients, including brain (BM), distant extracranial (ExM), and lymph node (LNM) metastases. BMs harbored the most somatic alterations compared to metastases in other sites. Despite the high concordance of putative driver alterations between paired primary tumors and metastases, PTPRD and FAT1 were highly enriched in BM-associated primary tumors. We discovered loss of early driver mutations by specific loss of heterozygosity in BMs. Monoclonal seeding is common in BMs (89%, 84/94) but relatively rarer in LNMs (41%, 74/179) and ExMs (49%, 19/39). Metastatic timing estimates indicated that BMs occur relatively later than LNMs. Collectively, our systematic analysis reveals distinct genomic features and evolutionary trajectories of BMs.